Anti-FcRn (FCGRT & B2M) Antibody (Rozanolixizumab)
Catalog No.
F1706
Anti-FcRn (FCGRT & B2M) Antibody (Rozanolixizumab)
Featured Products
Rozanolixizumab (UCB7665) is a humanized high-affinity anti-human neonatal Fc receptor (FcRn) monoclonal antibody (IgG4P) used in research to reduce pathogenic IgG in autoimmune and alloimmune diseases.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.2 kDa
Dry ice
1584645-37-3
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
UCB7665, Rystiggo
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P55899
Human, Cynomolgus
Unconjugated
Monoclonal
Protein A
IgG4SP
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized FcRn (FCGRT) His+FcRn (B2M) at 2 ug/mL can bind Anti-FcRn (FCGRT & B2M) Reference Antibody (rozanolixizumab)
FcRn (FCGRT & B2M)
Please avoid freeze-thaw cycles.